Additionally, in the bone marrow CD34+ cells of MDS patients, expression of CCL4, CCR5, and CCR1 is elevated compared to healthy controls [42], suggesting an autocrine action of CCL4. The gene discussed is CCR5; the disease is myelodysplastic syndrome.